Khadem Tina M, Nguyen M Hong, Mellors John W, Bariola J Ryan
Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Open Forum Infect Dis. 2022 Apr 11;9(6):ofac168. doi: 10.1093/ofid/ofac168. eCollection 2022 Jun.
Expanding antimicrobial stewardship to community hospitals is vital and now required by regulatory agencies. UPMC instituted the Centralized Health system Antimicrobial Stewardship Efforts (CHASE) Program to expand antimicrobial stewardship to all UPMC hospitals regardless of local resources. For hospitals with few local stewardship resources, we used a model integrating local non-Infectious Diseases (ID) trained pharmacists with centralized ID experts.
Thirteen hospitals were included. Eleven were classified as robust (4) or nonrobust (7) depending on local stewardship resources and fulfillment of Centers for Disease Control and Prevention core elements of hospital antimicrobial stewardship. In addition to general stewardship oversight at all UPMC hospitals, the centralized team interacted regularly with nonrobust hospitals for individual patient reviews and local projects. We compared inpatient antimicrobial usage rates at nonrobust versus robust hospitals and at 2 UPMC academic medical centers.
The CHASE Program expanded in scope between 2018 and 2020. During this period, antimicrobial usage at these 13 hospitals decreased by 16% with a monthly change of -4.7 days of therapy (DOT)/1000 patient days (PD) (95% confidence interval [CI], -5.5 to -3.9; < .0001). Monthly decrease at nonrobust hospitals was -3.3 DOT/1000 PD per month (-4.5 to -2.0, < .0001), similar to rates of decline at both robust hospitals (-3.3 DOT/1000 PD) and academic medical centers (-4.8 DOT/1000 PD) ( = .167).
Coordinated antimicrobial stewardship can be implemented across a large and diverse health system. Our hybrid model incorporating a central team of experts with local community hospital pharmacists led to usage decreases over 3 years at a rate comparable to that seen in larger hospitals with more established stewardship programs.
将抗菌药物管理扩展至社区医院至关重要,且目前监管机构有此要求。匹兹堡大学医学中心(UPMC)设立了集中式医疗系统抗菌药物管理项目(CHASE),以将抗菌药物管理扩展至所有UPMC医院,无论其当地资源状况如何。对于当地管理资源较少的医院,我们采用了一种模式,将当地未接受感染性疾病(ID)培训的药剂师与集中式ID专家相结合。
纳入了13家医院。根据当地管理资源以及是否满足疾病控制与预防中心医院抗菌药物管理的核心要素,其中11家被归类为资源丰富型(4家)或资源不丰富型(7家)。除了对所有UPMC医院进行一般管理监督外,集中式团队还定期与资源不丰富的医院互动,以进行个体患者评估和当地项目。我们比较了资源不丰富型医院与资源丰富型医院以及两家UPMC学术医疗中心的住院患者抗菌药物使用率。
CHASE项目在2018年至2020年期间扩大了范围。在此期间,这13家医院的抗菌药物使用量下降了16%,每月治疗天数(DOT)减少-4.7天/1000患者日(PD)(95%置信区间[CI],-5.5至-3.9;P<0.0001)。资源不丰富型医院每月减少-3.3 DOT/1000 PD(-4.5至-2.0,P<0.0001),与资源丰富型医院(-3.3 DOT/1000 PD)和学术医疗中心(-4.8 DOT/1000 PD)的下降率相似(P=0.167)。
可以在一个庞大且多样化的医疗系统中实施协调一致的抗菌药物管理。我们将专家中央团队与当地社区医院药剂师相结合的混合模式,在3年内使抗菌药物使用量下降,下降速度与管理项目更成熟的大型医院相当。